PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $45.8 Million for April 2022

12 May 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at Two Healthcare Conferences in May

10 May 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports First Quarter 2022 Financial Results

04 May 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira to Report First Quarter 2022 Financial Results on Wednesday May 4, 2022

27 Apr 2022 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Revenues of $157.4 to $158.4 Million for the First Quarter of 2022

12 Apr 2022 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference

05 Apr 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $42.6 Million for February 2022

15 Mar 2022 08:00:03 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare Conference

09 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results

24 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira to Report 2021 Financial Results on Thursday February 24, 2022

16 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37.3 Million for January 2022

15 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira Reports Preliminary Unaudited Total Revenue for 2021 of $540.7 Million to $541.7 Million

06 Jan 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

03 Jan 2022 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B

09 Dec 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021

07 Dec 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

23 Nov 2021 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management

19 Nov 2021 08:40:10 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the Jefferies London Healthcare Conference

10 Nov 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021

09 Nov 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira Files Lawsuit Against eVenus for Patent Infringement

08 Nov 2021 16:30:14 By Nasdaq GlobeNewswire